This article needs additional citations for verification. (December 2024) |
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies[which?] to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
![]() | |
![]() | |
Company type | Public |
---|---|
NSE: STRIDES BSE: 532531 | |
Industry | Pharmaceutical |
Founded | 1990 |
Headquarters | Bannerghatta Road, Bangalore, India |
Key people | Arun Kumar (Founder and Chairman) |
Products | Hard gelatin, solid dosage, Tablets, Formulations |
Revenue | ![]() |
Website | www |
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab.[2] In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.[3]
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception.[4]
Manufacturing
editIndian plants
editIn India the company operates eight pharmaceutical plants:
- KRSG Anekal - The company has a manufacturing plant at Jigani in the taluka of Anekal in the southern part of the Bangalore metropolitan area. The plant makes soft gelatin capsules, hard gelatin capsules, tablets and ointments.
- STAR - Strides Technology & Research - the R&D centre at Bannerghata Road (opp. IIM-B, Bangalore)
On 5 December 2013, the company announced that it had completed the sale of its Agila Specialties Division to Mylan Inc., for a total sum of up to US$1.75 billion.[citation needed]
Non-Indian plants
edit- Europe - Italy (Beltapharm S.pA)
Global Disease Initiative
editStrides operates in the international market for generics to fight HIV/ AIDS, TB and malaria. The company works with the Clinton Foundation to supply lower cost anti-retroviral drugs for the treatment of HIV/AIDS as part of the Clinton Foundation's HIV/AIDS initiative. The company is also on the list of World Health Organization pre-qualified suppliers to supply generic fixed dose combination of anti-HIV drugs. It is an approved supplier to the World Bank, the African Development Bank, PEPFAR President's Emergency Plan For AIDS Relief and UNICEF.
References
edit- ^ "Strategy to delivery" (PDF). Archived from the original (PDF) on 4 April 2015.
- ^ PTI (19 November 2015). "Strides Arcolab changes name to Strides Shasun Ltd". Business Standard. Retrieved 6 August 2018.
- ^ Shasun Pharmaceuticals to merge with Strides Arcolab
- ^ Arun Kumar aims to reinvent Strides Arcolab with eye on new opportunities